Piper Jaffray Gives Investors Its Thoughts On The FDA Approval Of Insys Therapeutics Anorexia Drug Syndros

Insys Therapeutics Inc (NASDAQ: INSY) announced the FDA approval of Syndros, and is waiting on a controlled substance designation ...